The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment of liver metastases in patients with neuroendocrine tumors: A National Comprehensive Cancer Network analysis.
Michael A. Choti
Research Funding - Ipsen
Sarah Bobiak
Employment or Leadership Position - Bristol-Myers Squibb (I)
Mark Bloomston
No relevant relationships to disclose
Carrie C. Zornosa
No relevant relationships to disclose
Emily K. Bergsland
No relevant relationships to disclose
Jonathan R. Strosberg
No relevant relationships to disclose
Al Bowen Benson
Consultant or Advisory Role - Bayer/Onyx; Biocompatibles; Daiichi Sankyo; Genentech; Genomic Health; Infinity; Lilly; Precision Therapeutics; Vista Med
Research Funding - Abbott Laboratories; Amgen; Astellas Pharma; Bayer/Onyx; Genentech/Roche; Gilead Sciences; MDS Nordion
Other Remuneration - Genentech/Roche
Matthew Kulke
Consultant or Advisory Role - Ipsen; Lexicon; Novartis; Pfizer
Manisha H. Shah
Research Funding - Novartis
Eric K. Nakakura
No relevant relationships to disclose
James C. Yao
No relevant relationships to disclose